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CLINICAL INVESTIGATION
Association Between Episodic Memory and Genetic Risk Factors
for Alzheimer’s Disease in South Asians from the Longitudinal
Aging Study in India–Diagnostic Assessment of Dementia
(LASI-DAD)
Jennifer A. Smith, PhD,*† Wei Zhao, PhD,* Miao Yu, MS,* Kalee E. Rumfelt, BS,*
Priya Moorjani, PhD,‡§ Andrea Ganna, PhD,¶ Aparajit B. Dey, MD,∥ Jinkook Lee, PhD,** and
Sharon L.R. Kardia, PhD*
BACKGROUND/OBJECTIVES: Genetic factors play an
important role in Alzheimer’s disease (AD) and cognitive
aging. However, it is unclear whether risk loci identified in
European ancestry (EA) populations have similar effects in
other groups, such as South Asians.
DESIGN: We investigated the allelic distribution and cogni-
tive associations of 56 known AD risk single-nucleotide
polymorphisms (SNPs) identified from three EA genome-
wide association studies (EA-GWASs) in a South Asian
population. Single SNP and genetic risk score (GRS) associ-
ations with measures of episodic memory were assessed.
SETTING: The Diagnostic Assessment of Dementia for the
Longitudinal Aging Study in India (LASI-DAD).
PARTICIPANTS: A total of 906 LASI-DAD participants
from diverse states in India.
MEASUREMENTS: Participants were genotyped using the
Illumina Global Screening Array and imputed with 1000G
Phase 3v5. Cognitive measures included total learning and
delayed word recall.
RESULTS: Although only a few SNPs were significantly
associated with memory scores (P < .05), effect estimates
from the EA-GWAS and the LASI-DAD showed moderate
correlation (0.35–0.88) in the expected direction. GRSs
were also associated with memory scores, although percent-
age variation explained was small (0.1%–0.6%).
CONCLUSIONS: Discrepancies in allele frequencies and
cognitive association results suggest that genetic factors
found predominantly through EA-GWASs may play a lim-
ited role in South Asians. However, the extent of differences
in the genetic architecture of AD and cognition in EA and
South Asians remains uncertain. There is also a critical need
to perform a more comprehensive assessment of the muta-
tional spectrum of South Asia to identify novel genetic vari-
ants associated with AD and cognition in this population. J
Am Geriatr Soc 68:S45-S53, 2020.
Keywords: Alzheimer’s disease; cognition; genetics;
South Asian; Indian
INTRODUCTION
Alzheimer’s disease (AD) is a progressive form ofdementia with pronounced impairment in memory.
Recently, genetic factors have been linked to AD, and the
estimated heritability of AD is as high as 80%.1-3 The
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strongest genetic risk factor is the ε4 allele of the apolipo-
protein E (APOE) gene, with an odds ratio (OR) of 14.9 in
individuals who carry two ε4 alleles versus noncarriers.4,5
However, the ε2 allele of APOE is protective from AD.6,7
Genome-wide association studies (GWASs) have identi-
fied other genetic risk factors for AD. The first large-scale
GWAS of AD, conducted by Lambert and colleagues using
74,046 AD cases and controls, identified 19 AD risk loci in
addition to APOE.8 Recently, Kunkle et al expanded the
discovery cohort (N = 94,437) and identified 25 AD risk
loci in total, 7 of which were new.9 A third GWAS, con-
ducted by Jansen et al,10 added UK Biobank data and
included both clinically diagnosed AD and AD-by-proxy
(through parental diagnosis) cases (N = 455,258). They
identified 29 risk loci, including 12 that were novel.10
Taken together, these AD GWASs identified 66 unique AD-
associated single-nucleotide polymorphisms (SNPs) from
38 loci in addition to APOE (Supplementary Table S1).
Importantly, all three AD GWASs were conducted
among European ancestry (EA) partcipants.8-10 Currently,
there are no large-scale AD GWASs in Indian or South
Asian populations. This is problematic because populations
may have different linkage disequilibrium (LD) patterns due
to their unique evolutionary history, potentially resulting in
genetic heterogeneity across ancestries.11 Most South Asian
groups descended from a mixture of two genetically diver-
gent populations: ancestral North Indians related to Central
Asians, Middle Easterners, Caucasians, and Europeans; and
ancestral South Indians not related to any groups outside of
the subcontinent.12,13 Following the mixture, a major
demographic shift toward endogamy led to strong founder
events more extreme than in Ashkenazi Jews or Finns.13,14
As a result, LD structure and allele frequencies differ sub-
stantially not only between South Asian and European
populations, but also across neighboring groups in India.15
Further, genetic predictors of dementia may differ between
EA and South Asian populations due to differences in envi-
ronmental factors (including diet, toxicants, or socioeco-
nomic status), which may interact with or overshadow
genetic risk factors. Therefore, is not clear whether genetic
loci previously identified in EA-GWASs will perform simi-
larly in South Asians.
To assess the transferability of genetic risk variants dis-
covered through EA-based AD GWASs to South Asians, we
evaluated the effect of these variants with cognitive function
in participants of the Longitudinal Aging Study in India–
Diagnostic Assessment of Dementia (LASI-DAD). We tested
66 unique AD-associated SNPs from three GWASs to pre-
sent an inclusive set of SNPs, representing both highly repli-
cated, larger-effect AD risk variants8 and newly discovered,
smaller-effect AD risk variants from studies with larger
sample sizes and/or broader case definitions.9,10 We also
evaluated the effect of APOE ε4 and ε2 alleles. Both single




The LASI is a nationally representative sample of greater
than 70,000 adults from India aged 45 years or older.
LASI-DAD, an add-on study, includes the Harmonized
Cognitive Assessment Protocol (HCAP), informational
interviews, and blood draws for approximately 3,000 LASI
respondents aged 60 years or older. To guarantee a suffi-
cient number of respondents with dementia and mild cogni-
tive impairment, a stratified random sample design was
implemented.16
Genotyping and Imputation
The Illumina Infinium Global Screening Array-24 (GSA)
BeadChip, version 2.0 (Illumina) was used to genotype
960 LASI-DAD participants. Genotypes were imputed to
the 1000G Project worldwide reference panel (phase 3, ver-
sion 5). Principal component (PC) analysis17 was used to
exclude outliers and select a set of 932 unrelated individuals
for analysis. The top 10 PCs were included in all analyses
to adjust for population stratification. Supplemental
Methods provides additional details.
Cognitive Measures and Covariates
A battery of cognitive tests was administered, including a
common set of cognitive tests from the HCAP16 to enable
international comparisons and additional cognitive tests
suitable for illiterate and innumerate populations. Cognitive
measures analyzed were total learning score (0–30 words)
and delayed word recall score (0–10 words). Cognitive tests
and surveys were translated into 10 local languages. Educa-
tion level was categorized as less than lower secondary edu-
cation, upper secondary education/vocational training, or
tertiary education. A total of 906 individuals had genotype
data, covariate data (sex, age, and education), and at least
one cognitive measurement.
Association Between SNPs and Cognitive Function
We compared the allelic distribution of the AD risk SNPs
between LASI-DAD and the EA-GWAS samples by calcu-
lating the correlation coefficient of the risk allele frequency
across all SNPs. We assessed whether allele frequency of
each SNP differed between LASI-DAD and EA-GWAS sam-
ples using a one-sample proportion test.
Linear regression was used to assess whether each SNP
was associated with total learning and/or delayed recall
scores in LASI-DAD, using two models. Model 1 adjusted
for age, sex, and the top 10 genetic PCs, and model 2 addi-
tionally adjusted for education. We hypothesized that AD
risk alleles would be associated with lower cognitive func-
tion. We assessed results at a nominal significance level
(P ≤ .05) as well as a Bonferroni-corrected significance level,
accounting for the number of SNPs analyzed. We assessed
the correlation of the risk allele effect sizes on cognitive
function in LASI-DAD with the effect sizes on AD reported
from the three AD GWASs. We further tested SNP-by-age
interactions to evaluate whether effect sizes vary by age.
Association Between GRSs and Cognitive Function
Three GRSs were constructed using all the identified AD
risk SNPs from each AD GWAS separately. Note that there
is overlap in some of the SNPs that comprise these three
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scores. We excluded variants in the APOE region from the
three GRSs and treated APOE as an independent signal.
Each GRS was calculated as GRSj =
P
βixij, with βi being
the effect size associated with the risk allele for SNP i, and xij
being the dosage of the risk allele for SNP i in individual j.
The effect size of each SNP was calculated as the
ln(OR) reported in the corresponding GWAS article. We
assessed whether each GRS was associated with total learn-
ing or delayed recall using the regression models above. We
then combined the three GRSs into a single multivariable
model to assess the total variance in cognitive function
explained before and after adding APOE ε2 and ε4.
Sensitivity Analysis of the APOE Region
Because APOE is known to be the most important risk locus
for AD, we also tested the association between all SNPs in
APOE (plus 2 kb upstream to capture the promoter region)
and memory scores. For SNPs associated with any memory
score, we tested for interaction with ε4 and ε2.
RESULTS
Descriptive Statistics
The LASI-DAD sample was 44% male, and study participants
were 69 years old (standard deviation (SD) = 7.2 years) on
average (Table 1). Most participants attained lower than sec-
ondary level education (70.0%), and over half were from a
rural area. Participants had a mean of 12.0 and 3.4 words
(SD = 5.2 and 2.4 words) for total learning and delayed recall
scores, respectively. The correlation between memory scores
was r = 0.73 (P < .0001).
Genotype and Imputation Quality in LASI-DAD
Among those genotyped, the median call rate was excellent
(99.95%), and the estimated error rate was low
(1.5 × 10−6). The mean EmpRsq (correlation between the
true genotypes and imputed dosages calculated by masking
the given SNP) was 0.86 for common variants (minor allele
frequency [MAF] > 0.05), indicating relatively high quality,
but was lower (0.66) for rare variants (MAF ≤0.05, com-
prising 84.7% of the measured variants).
Allelic Distribution of the AD Risk Loci
Among the 68 unique SNPs, 27 were directly genotyped on
the GSA, and another 29 were successfully imputed with
high quality (r2 > 0.8). One SNP was not available because
it was not included in the 1000G reference panel, and
another 12 SNPs were excluded due to poor imputation
quality in LASI-DAD. As a result, 56 unique SNPs were
investigated (Supplementary Tables S1 and S2).
Figure 1 compares the risk allele frequencies of all
56 unique SNPs in LASI-DAD versus the corresponding AD
GWAS. Although the risk allele frequencies are correlated
as expected (r = 0.91; P < .0001), 47 SNPs had a signifi-
cantly different allele frequency between LASI-DAD and the
AD GWAS samples (P ≤ .05; Supplementary Table S3). We
Table 1. Characteristics of the LASI-DAD Sample
(N = 906)
Characteristic Mean or No. SD or %
Age, y 69.16 7.22
Male sex 400 44.2
Total learning score (words)a 12.01 5.15
Delayed recall score (words)b 3.35 2.43
Education
Less than lower secondary 634 70.0
Upper secondary/vocational training 233 25.7
Tertiary 39 4.3
Caste
1. Scheduled caste 170 18.8
2. Scheduled tribe 17 1.9
3. Other backward class 450 49.7
4. None of them 269 29.7
Urban/rural
Urban community 400 44.2
Rural village 506 55.8
Abbreviation: LASI-DAD, Longitudinal Aging Study in India–Diagnostic
Assessment of Dementia.
aTotal learning score, N = 899.
bDelayed recall score, N = 893.
Figure 1. Scatterplot of the risk allele frequencies from
Alzheimer’s disease (AD) genome-wide association study
(GWAS) and Longitudinal Aging Study in India–Diagnostic
Assessment of Dementia (LASI-DAD) sample. The risk allele
frequencies of the 60 AD-associated single-nucleotide polymor-
phisms (SNPs) (56 unique SNPs and 3 SNPs that appeared in
multiple articles) in LASI-DAD (y axis) are compared with the
corresponding risk allele frequencies reported in the 3 AD
GWASs (x axis). As shown, the risk allele frequencies of SNPs
in LASI-DAD correlated well with those from the European
ancestry AD GWAS samples (correlation = 0.91). The risk
allele frequencies of APOE ε2 and ε4 variants are taken from
Jansen et al.10
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note that this frequency comparison will be slightly biased
toward the null because GWAS studies are best powered to
detect more common variants. Thus, the SNPs identified in
GWAS would have less variability in allele frequencies
compared with an unselected set of SNPs. The variance
ratio of the risk allele frequencies in the GWAS samples
and LASI-DAD is 0.81, slightly lower than 1. Thus, the
influence of the bias, if it exists, is relatively small.
Association Between Single SNPs and Cognitive
Measures
Associations between each AD risk SNP and each cognitive
measure were assessed using two models. Model 1 adjusted
for age, sex, and the top 10 genetic PCs, and model 2 addi-
tionally adjusted for education. Q-Q plots indicate that in
both models, P values from the 56 SNPs were generally
smaller than expected by chance alone (Supplementary
Figure S1). This suggests some evidence of association
between the AD risk SNPs and cognitive measures.
All nominally significant association results (P ≤ .05)
are presented in Table 2. Of the 56 SNPs assessed, 10 were
nominally associated with total learning and/or delayed
recall score (Table 2). Among the 10 SNPs, 3 (rs2830500
(ADAMTS1), rs10948363 (CD2AP6), and rs11218343
(SORL1)) were associated with both memory scores in
model 1. Two SNPs (rs1859788 (ZCWPW1) and
rs7185636 (IQCK)) were associated with total learning
score only, and one SNP (rs9473117 (CD2AP)) was associ-
ated with delayed recall score only in model 1. Significance
was attenuated for rs2830500 (ADAMTS1) and rs1859788
(ZCWPW1) for total learning score after controlling for
education (model 2). In contrast, four SNPs (rs4147929
and rs2752246 in ABCA7 and rs6733839 and rs4663105
in BIN1) show a stronger association with total learning
and/or delayed recall in model 2 than model 1. However,
no associations remained significant after Bonferroni correc-
tion (P ≤ 8.9 × 10−4). Among the 10 SNPs, most demon-
strated an association in the expected direction, where AD
risk alleles were associated with lower memory score. Nei-
ther the APOE ε2 nor ε4 allele was associated (P ≤ .05)
with memory scores, although the effect directions were as
expected.
Although only a small number of the 56 SNPs were sig-
nificant, most had the expected effect directions (62.5% for
total learning and 57.1% for delayed recall in model 1;
Supplementary Table S4). AD risk alleles were generally
associated with decreased cognition in LASI-DAD
(r between effect estimates ranges from −0.35 to −0.88;
Supplementary Table S5, Supplementary Figure S2). SNPs
with larger GWAS effect sizes tended to have the expected
direction of effect in our study; however, those with smaller
effect sizes did not always have the expected effect direc-
tion. Thus, the relatively strong correlation may not neces-
sarily reflect consistent effects of AD risk variants on
cognition.
Among 56 tested SNPs, 6 interacted with age at
P ≤ .05 in one or multiple models (Supplementary
Table S6), but none was significant after Bonferroni correc-
tion, suggesting that the SNP effects do not vary substan-
tially by age.
Association Between GRSs and Cognitive Measures
The distribution of the three GRSs (constructed from three
AD GWASs) are presented in Supplementary Figure S3. As
Table 4. GRS Associations with Cognitive Function
Article
Total learning score Delayed recall score
Model 1 Model 2 Model 1 Model 2
β P value R2, % β P value R2, % β P value R2, % β P value R2, %
GRS (Lambert et al8) −.313 .050 0.4 −.252 .089 0.2 −.094 .219 0.1 −.066 .361 0.1
GRS (Kunkle et al9) −.420 .008 0.6 −.317 .032 0.4 −.179 .018 0.5 −.136 .059 0.3
GRS (Jansen et al10) −.215 .178 0.2 −.145 .330 0.1 −.068 .376 0.1 −.039 .588 0.02
GRS (Lambert et al8) +
GRS (Kunkle et al9) +
GRS (Jansen et al10)
0.7 0.4 0.7 0.4
GRS (Lambert et al8) + GRS (Kunkle et al9) +
GRS (Jansen et al10) + rs7412 (ε2) +
rs429358 (ε4)
0.8 0.4 0.8 0.4
Note: P ≤ .05 is indicated by bold text. GRS effects sizes (β values) are calculated with respect to an increasing number of Alzheimer’s disease risk alleles.
Model 1: cognitive measure  GRS + sex + age + principal component (PC) 1 – PC10. Model 2: cognitive measure  GRS + sex + age + education + PC1 –
PC10. R2 represents the variance in the cognitive measure explained by the individual GRS, three GRSs combined, or GRSs combined with APOE variants.
Abbreviation: GRS, genetic risk score.









GRS (Lambert et al8) 1.000
GRS (Kunkle et al9) 0.798 1.000
GRS (Jansen et al10) 0.567 0.592 1.000
Note: All GRSs are standardized to a N(0,1) distribution.
Abbreviations: GRS, genetic risk score; GWAS, genome-wide association
study.
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expected, the GRSs were positively correlated with each
other (Table 3). However, none of the correlations was
strong, suggesting that they capture similar but distinct
genetic risk profiles in LASI-DAD.
In regression model 1, the Lambert et al8 GRS and the
Kunkle et al9 GRS were negatively associated with total
learning score (Table 4), and the Kunkle et al9 GRS was
negatively associated with delayed recall score. In model
2, the Kunkle et al9 GRS was associated with total learning
score, but all other GRSs were attenuated. The proportion
of variance in total learning score explained by each GRS
ranged from 0.2% to 0.6% in model 1 and from 0.1% to
0.4% in model 2. When combined together, the three GRSs
explained 0.7% and 0.4% of variance in model 1 and
model 2, respectively. When further combined with APOE
ε4 and ε2, they explained 0.8% in model 1 and 0.4% in
model 2. Compared with total learning score, the propor-
tion of variance in delayed recall score explained by each
GRS showed a similar pattern but was smaller.
Sensitivity Analysis of the APOE Region
There were 10 SNPs within APOE (plus the 2-kb promoter)
region in LASI-DAD. Among the 10 SNPs, all 3 SNPs in
the promoter region (rs7256173, rs7259620, and
rs405509) and 2 SNPs within the gene (rs440446 and
rs769450) were nominally associated with total learning
score in models 1 and/or 2 at P ≤ .05 (Supplementary
Table S7). Two SNPs (rs7259620 and rs440446) remained
significant after Bonferroni correction (P ≤ .005).
We further tested the interaction of these SNPs with
both rs429358 (ε4) and rs7412 (ε2). We observed a nomi-
nally significant interaction (P ≤ .05) between rs7256173
and rs429358 (ε4) for both total learning and delayed recall
scores in models 1 and 2, and a significant interaction
between rs440446 and rs7412 (ε2) on delayed recall score
in model 2 (Supplementary Table S8). The interaction
between rs7256173 and rs429358 (ε4) on total learning
score remained significant after Bonferroni correction
(P ≤ .01). Suggestive evidence of interactions (P < .1) were
observed for rs405509 by rs429358 (ε4) on total learning
score in model 2, rs440446 by rs7412 (ε2) on both memory
scores in models 1 and 2, and rs405509 by rs7412 (ε2) for
both memory scores in model 2.
DISCUSSION
We investigated the association between AD-associated
SNPs identified from EA-GWASs and cognitive function in
a South Asian cohort. Many of the AD risk variants had
different allele frequencies in LASI-DAD compared with
EA-GWAS samples. This could be due to differences in
study design. Neither LASI-DAD nor the EA-GWASs are
fully population-representative. EA-GWAS samples are
mostly case-control studies, and LASI-DAD is a substudy of
the population-representative LASI study, with
oversampling those at high risk for cognitive impairment.
On the other hand, there could be true differences in allele
frequency between the two populations. This would not be
surprising due to strong founder events in Indian/South
Asian populations.18 Differences in LD patterns between
European and Indian/South Asian ancestries may also cause
different SNPs at the same genes/loci to be more strongly
associated with AD in each population. Further, because
Indians/South Asians derive more than half of their ancestry
from a founding population that no longer exists in an
unmixed form and is significantly divergent from other
extant populations, it is unlikely that all of the variants
identified in the EA populations are directly transferrable to
Indian/South Asian populations.11,14
Genetic predictors of dementia may also differ between
populations when there are major differences in environ-
mental risk factors. Dementia and cognitive decline may
result from AD-related neurodegeneration, but also from
other common disease processes, such as cardiovascular dis-
ease. The prevalence of hypertension has increased rapidly
in India due to longer life expectancy and westernization in
lifestyle.19 Previous studies indicate a larger burden of vas-
cular dementia over AD in Asian populations, whereas AD-
related dementia is more prevalent in EA.20 Also, LASI-
DAD participants differ in other ways from EA-GWAS par-
ticipants, including diet (e.g., enriched with curcumin spice),
natural environment (e.g., greater exposure to various pol-
lutants), and social environment (e.g., lower socioeconomic
status and education levels). These environmental factors
may be associated with dementia/cognition alone and/or
through interaction with genetic risk factors.21-25 Thus, the
underlying genetic risk factors may differ in these
populations. It is therefore critical to validate the effects of
AD risk variants in Indians/South Asians.
Although India is the second largest country in the
world, it is rarely represented in genomic studies.12 The
1000 Genomes Project only contains a small proportion
(13.6%) of Indians/South Asians, and they are not well rep-
resented in any other commonly used large reference panel,
including the Trans-Omics for Precision Medicine and the
Haplotype Reference Consortium.26 As a result, some of
the SNPs had low imputation quality in LASI-DAD, and
thus could not be evaluated in this study. Imputation qual-
ity was especially low for rare variants, as has been previ-
ously demonstrated.27 Therefore, large-scale, population-
based Indian/South Asian sequencing projects are needed to
attain a representative reference panel that would allow for
higher-quality imputation for future Indian/South Asian-
based studies and facilitate efforts to identify new variants
linked to AD and other diseases.
This study suggests that EA-GWAS AD risk variants
confer a small amount of genetic risk for decreased cogni-
tive function in Indians/South Asians. Therefore, previously
identified AD risk variants may not be the most prominent
or the only risk variants in Indians/South Asians. At a nom-
inal P value, risk variants in ADAMTS1, ZCWPW1,
IQCK, BIN1, and SORL1 were associated with decreased
cognitive function in LASI-DAD. Among them, BIN1,
SORL1, and ZCWPW1 were the early identified risk loci in
Lambert et al.8 BIN1 is one of the most strongly associated
loci for AD after APOE. The gene is expressed primarily in
the central nervous system and is believed to activate a
caspase-independent apoptotic process.28 ZCWPW1 is a
histone modification reader and potentially involved in pho-
sphoinositide 3-kinase signaling pathways in neurons.29
The association between both loci and AD has been
reported in East Asians, although the implicated SNPs were
not the same.29,30 Interestingly, the variant we examined at
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the ZCWPW1 locus (rs1859788) is a missense mutation
and has been recently suggested to likely be a causal allele
for AD.31 SORL1 encodes a type I transmembrane protein
that helps facilitate lipid reception through endocytosis and
sorting of fats. The T allele of rs1121834 in SORL1 was
associated with increased risk of late-onset AD in East
Asians.32,33 The suggestive evidence of associations
observed in LASI-DAD suggest that these loci are likely to
have similar function in Indians/South Asians and EA.
ADAMTS1 and IQCK were novel loci that were identi-
fied by the recent AD GWASs (ADAMTS1 in both Kunkle
et al9 and Jansen et al10; IQCK in Kunkle et al9).
ADAMTS1 encodes a zinc-binding enzyme excreted in sev-
eral adult tissues that is required for normal ovulation and
renal function,34 and has been linked to breast cancer.35
IQCK encodes a protein with an IQ motif that allows for
binding of EF-hand proteins and has been linked to obses-
sive compulsive disorder.36 Additional studies are needed to
understand the roles of these genes in AD and cognition.
Interestingly, two SNPs from CD2AP and two SNPs
from ABCA7 were nominally associated with increases in
total learning and delayed recall scores. CD2AP encodes a
scaffolding protein that supports the integrity of inter-
cellular junctions. ABCA7 encodes a multispan transmem-
brane protein that is highly expressed in the brain,
facilitating transport of phospholipids and cholesterol
across cell membranes.37 Associations between SNPs in
these two genes and AD in East Asian cohorts have shown
mixed results.38,39 Similar to our study, a study in approxi-
mately 850 Koreans found that several AD risk variants in
Europeans were actually protective for AD at a nominal sig-
nificance level, including the A allele of rs4147932, which
also shows the unexpected direction of effect in our study
as well.40 Thus, CD2AP and ABCA7 likely play a role in
AD and/or cognition in Indians/South Asians, although the
involved risk variants may differ from EA. We also noted
that none of the results from these genes remained signifi-
cant after multiple testing correction in our study, and thus
should be interpreted cautiously.
The two APOE major isoforms were not associated
with memory scores in LASI-DAD, although the effect esti-
mates were in the expected direction. APOE is the strongest
genetic risk locus for AD in multiple populations, including
Asians.41 Two recent meta-analyses show that APOE ε4 is
associated with AD in Indians, with similar effect sizes as in
EA (OR ranging from 4.14 to 5.90).42,43 Interestingly, one
study found that APOE ε3 instead of ε2 showed suggestive
evidence of protection against AD in Indians.43 The lack of
association between APOE major isoforms and cognition in
this study may be due to our examination of memory scores
rather than diagnosed AD, which are not necessarily good
predictors of AD risk.44,45 Prior studies found that the asso-
ciation between APOE and memory performance/cognition
was much weaker than with AD.46,47 In addition, the associ-
ation may be age dependent, with stronger associations at
older ages.48-50 Further, ε4 is more strongly associated with
story-based than word-based memory tasks.48 Consistent
with our study, multiple studies in Asians failed to find an
association between APOE variants and cognition.51,52
Although poor episodic memory/cognition is a key symptom
of AD, it may also be a consequence of other health condi-
tions, such as Huntington’s disease, Parkinson’s disease,
hypertension, and others.53-56 Thus, lack of association for
APOE major isoforms, and possibly for other AD risk vari-
ants, may be due to the outcomes investigated in this study.
In addition to APOE major isoforms, many studies sug-
gest that the variants in the promotor region and intron 1, in
particular rs405509 and rs440446, were associated with
cognitive function/AD independently or through interaction
with the major APOE isoforms.57-60 Consistent with this lit-
erature, the same SNPs along with three other variants (two
in the promoter region) were associated with total learning
score in this study. Furthermore, we observed a significant
interaction between a promoter SNP and ε4 on both total
learning score and delayed recall score as well as suggestive
evidence of interaction that includes both rs405509 and
rs440446. This evidence suggests that APOE is probably an
important risk locus for dementia in Indians/South Asians as
well, but that multiple variants and mechanisms might be
involved. Nonetheless, given that we investigated memory
rather than AD, there is still tremendous uncertainty regard-
ing the effect of these genetic risk factors on AD in South
Asians. Future studies that focus on clinically diagnosed AD
in this population will be the essential next step to compare
the SNP effect sizes across populations and better understand
the genetic architecture of AD in South Asians.
Although most AD risk variants were not strongly
associated with cognitive function, GRSs composed of these
variants did show association with cognitive function in
LASI-DAD. The GRS constructed from Kunkle et al9 per-
formed best among all three GRSs, possibly because this
study is the best-powered GWAS with clinically diagnosed
AD cases. Although Jansen et al10 have a much larger sam-
ple size, the case definition for this GWAS included both
clinically diagnosed AD as well as AD by proxy (parental
diagnosis). The additional cases identified through proxy
may have introduced bias or noise to the analysis, reducing
predictive ability of the GRS from this GWAS. Another
contributing factor may be that approximately one-third of
the risk variants from Jansen et al10 were from novel loci
with potentially small and hard-to-replicate effects. Thus,
the GRS from Jansen et al10 may have lower signal/noise
ratio compared with other GRSs. The combined GRSs plus
APOE ε4 and ε2 accounted for less than 1% of the vari-
ance in LASI-DAD memory scores. This explains drastically
less than the 16% AD variance explained by AD risk vari-
ants in EA (APOE ε4 and ε2 explained 13%, whereas other
genes explained 3%).53 Given the low variance explained in
LASI-DAD, we caution against applying EA-based genetic
knowledge to Indians/South Asians in a clinical setting.
In summary, this was the first study to comprehensively
survey all AD risk variants identified in three large-scale
AD GWASs and examine their association with cognitive
function in an Indian/South Asian population. This study
demonstrated some evidence of association between AD
risk variants and lower cognition, although the effect sizes
were small. A GRS of the known AD risk variants
explained less than a percentage of the total variance in
cognitive function, suggesting that many AD risk loci in
Indians/South Asians may remain to be identified. There-
fore, future large-scale AD GWASs and whole genome
sequence analysis in Indian/South Asian samples are
warranted to better characterize and understand the genetic
cause of AD in this population.
JAGS AUGUST 2020-VOL. 68, NO. S3 ALZHEIMER’S SNPs AND MEMORY IN SOUTH ASIANS S51
ACKNOWLEGEMENTS
Financial Disclosure: This project is funded by the
National Institute on Aging (R01 AG051125 and RF1
AG055273). The National Institute on Aging had no role
in preparing the data or the manuscript.
Conflict of Interest: The authors have no conflicts of
interest to disclose.
Author Contributions: J.A.S., W.Z., J.L., and S.L.R.K.:
Study concept and design. J.A.S., W.Z., and M.Y.: Statisti-
cal analyses. J.A.S., W.Z., M.Y., and K.E.R.: Manuscript
preparation. A.B.D., J.L., and S.L.R.K.: Data collection and
study supervision. P.M., A.G., A.B.D., J.L., and S.L.R.K.:
Critical revision of the manuscript.
Sponsor’s Role: The study sponsors had no role in the
design and conduct of the study; in the collection, analysis,
and interpretation of the data; or in the preparation, review,
or approval of the manuscript.
REFERENCES
1. Breteler MMB. Vascular risk factors for Alzheimer’s disease: an epidemio-
logic perspective. Neurobiol Aging. 2000;21:153-160.
2. Bird TD. Genetic factors in Alzheimer’s disease. N Engl J Med. 2005;352:
862-864.
3. Gatz M, Pedersen NL, Berg S, et al. Heritability for Alzheimer’s disease: the
study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci. 1997;52:
M117-M125.
4. Nguyen D, Dhanasekaran P, Phillips MC, Lund-Katz S. Molecular mecha-
nism of apolipoprotein E binding to lipoprotein particles. Biochemistry.
2009;48:3025-3032.
5. Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease:
risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106-118.
6. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein
E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
7. Conejero-Goldberg C, Gomar JJ, Bobes-Bascaran T, et al. APOE2 enhances
neuroprotection against Alzheimer’s disease through multiple molecular
mechanisms. Mol Psychiatry. 2014;19:1243-1250.
8. Lambert J-C, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046
individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat
Genet. 2013;45:1452-1458.
9. Kunkle BW, Grenier-Boley B, Sims R, et al. Genetic meta-analysis of diag-
nosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau,
immunity and lipid processing. Nat Genet. 2019;51:414-430.
10. Jansen IE, Savage JE, Watanabe K, et al. Genome-wide meta-analysis iden-
tifies new loci and functional pathways influencing Alzheimer’s disease risk.
Nat Genet. 2019;51:404-413.
11. Martin AR, Gignoux CR, Walters RK, et al. Human demographic history
impacts genetic risk prediction across diverse populations. Am J Hum Genet.
2017;100:635-649.
12. Sengupta D, Choudhury A, Basu A, Ramsay M. Population stratification
and underrepresentation of Indian subcontinent genetic diversity in the 1000
genomes project dataset. Genome Biol Evol. 2016;8:3460-3470.
13. Reich D, Thangaraj K, Patterson N, Price AL, Singh L. Reconstructing
Indian population history. Nature. 2009;461:489-494.
14. Moorjani P, Thangaraj K, Patterson N, et al. Genetic evidence for recent
population mixture in India. Am J Hum Genet. 2013;93:422-438.
15. Bittles AH. Population stratification and genetic association studies in South
Asia. J Mol Genet Med. 2005;1:43-48.
16. Lee J, Banerjee J, Khobragade PY, Angrisani M, Dey AB. LASI-DAD study:
a protocol for a prospective cohort study of late-life cognition and dementia
in India. BMJ Open. 2019;9:e030300.
17. Zheng X, Levine D, Shen J, Gogarten SM, Laurie C, Weir BS. A high-
performance computing toolset for relatedness and principal component
analysis of SNP data. Bioinformatics. 2012;28:3326-3328.
18. Nakatsuka N,Moorjani P, Rai N, et al. The promise of discovering population-
specific disease-associated genes in South Asia. Nat Genet. 2017;49:1403-1407.
19. Nair T. Challenges of hypertension and dementia in the Indian subcontinent:
a review. J Hum Hypertens. 2019;33:568-574.
20. Catindig JA, Venketasubramanian N, Ikram MK, Chen C. Epidemiology of
dementia in Asia: insights on prevalence, trends and novel risk factors.
J Neurol Sci. 2012;321:11-16.
21. Peters R, Ee N, Peters J, Booth A, Mudway I, Anstey KJ. Air pollution and
dementia: a systematic review. J Alzheimers Dis. 2019;70:S145-S163.
22. Kulick ER, Elkind MSV, Boehme AK, et al. Long-term exposure to ambient
air pollution, APOE-ε4 status, and cognitive decline in a cohort of older
adults in northern Manhattan. Environ Int. 2020;136:105440.
23. Seifan A, Schelke M, Obeng-Aduasare Y, Isaacson R. Early life epidemiology of
Alzheimer’s disease–a critical review. Neuroepidemiology. 2015;45:237-254.
24. Moorman SM, Carr K, Greenfield EA. Childhood socioeconomic status and
genetic risk for poorer cognition in later life. Soc Sci Med. 2018;212:219-226.
25. Reddy PH, Manczak M, Yin X, et al. Protective effects of Indian spice curcumin
against amyloid-β in Alzheimer’s disease. J Alzheimers Dis. 2018;61:843-866.
26. McCarthy S, Das S, Kretzschmar W, et al. A reference panel of 64,976 hap-
lotypes for genotype imputation. Nat Genet. 2016;48:1279-1283.
27. Das S, Abecasis GR, Browning BL. Genotype imputation from large refer-
ence panels. Annu Rev Genomics Hum Genet. 2018;19:73-96.
28. Lee JH, Cheng R, Barral S, et al. Identification of novel loci for Alzheimer
disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic
individuals. Arch Neurol. 2011;68:320-328.
29. Gao Y, Tan MS, Wang HF, et al. ZCWPW1 is associated with late-onset
Alzheimer’s disease in Han Chinese: a replication study and meta-analyses.
Oncotarget. 2016;7:20305-20311.
30. Tan MS, Yu JT, Jiang T, Zhu XC, Guan HS, Tan L. Genetic variation in
BIN1 gene and Alzheimer’s disease risk in Han Chinese individuals. Neuro-
biol Aging. 2014;35:1781.e1-1788.e1.
31. Rathore N, Ramani SR, Pantua H, et al. Paired immunoglobulin-like type
2 receptor alpha G78R variant alters ligand binding and confers protection
to Alzheimer’s disease. PLoS Genet. 2018;14:e1007427.
32. Miyashita A, Koike A, Jun G, et al. SORL1 is genetically associated with
late-onset Alzheimer’s disease in Japanese, Koreans and Caucasians. PLoS
One. 2013;8:e58618.
33. Zhang C-C, Wang H-F, Tan M-S, et al. SORL1 is associated with the risk of
late-onset Alzheimer’s disease: a replication study and meta-analyses. Mol
Neurobiol. 2017;54:1725-1732.
34. Lee NV, Sato M, Annis DS, et al. ADAMTS1 mediates the release of anti-
angiogenic polypeptides from TSP1 and 2. EMBO J. 2006;25:5270-5283.
35. Malvia S, Bagadi SAR, Pradhan D, et al. Study of gene expression profiles of
breast cancers in Indian women. Sci Rep. 2019;9:10018.
36. Chen BJ, Mills JD, Takenaka K, Bliim N, Halliday GM, Janitz M. Charac-
terization of circular RNAs landscape in multiple system atrophy brain.
J Neurochem. 2016;139:485-496.
37. Fehér A, Juhász A, Pákáski M, Janka Z, Kálmán J. Association study of the
ABCA7 rs3752246 polymorphism in Alzheimer’s disease. Psychiatry Res.
2019;279:376-377.
38. Tan L, Yu JT, Zhang W, et al. Association of GWAS-linked loci with late-
onset Alzheimer’s disease in a northern Han Chinese population. Alzheimers
Dement. 2013;9:546-553.
39. Xiao Q, Liu Z-J, Tao S, et al. Risk prediction for sporadic Alzheimer’s disease using
genetic risk score in the Han Chinese population. Oncotarget. 2015;6:36955.
40. Chung SJ, Lee JH, Kim SY, et al. Association of GWAS top hits with late-
onset Alzheimer disease in Korean population. Alzheimer Dis Assoc Disord.
2013;27:250-257.
41. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on
the association between apolipoprotein E genotype and Alzheimer disease: a
meta-analysis. JAMA. 1997;278:1349-1356.
42. Shankarappa BM, Kota LN, Purushottam M, et al. Effect of CLU and PIC-
ALM polymorphisms on AD risk: a study from south India. Asian J Psy-
chiatr. 2017;27:7-11.
43. Agarwal R, Tripathi CB. Association of apolipoprotein E genetic variation in
Alzheimer’s disease in Indian population: a meta-analysis. Am J Alzheimers
Dis Other Demen. 2014;29:575-582.
44. Ivanoiu A, Adam S, Van der Linden M, et al. Memory evaluation with a
new cued recall test in patients with mild cognitive impairment and
Alzheimer’s disease. J Neurol. 2005;252:47-55.
45. Rabin LA, Paré N, Saykin AJ, et al. Differential memory test sensitivity for
diagnosing amnestic mild cognitive impairment and predicting conversion to
Alzheimer’s disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn.
2009;16:357-376.
46. Deary IJ, Whiteman MC, Pattie A, et al. Cognitive change and the APOE
epsilon 4 allele. Nature. 2002;418:932.
47. Small BJ, Rosnick CB, Fratiglioni L, Bäckman L. Apolipoprotein E and cog-
nitive performance: a meta-analysis. Psychol Aging. 2004;19:592-600.
48. Debette S, Ibrahim Verbaas CA, Bressler J, et al. Genome-wide studies of
verbal declarative memory in nondemented older people: the Cohorts for
Heart and Aging Research in Genomic Epidemiology consortium. Biol Psy-
chiatry. 2015;77:749-763.
49. Liu F, Pardo LM, Schuur M, et al. The apolipoprotein E gene and its age-
specific effects on cognitive function. Neurobiol Aging. 2010;31:1831-1833.
S52 SMITH ET AL. AUGUST 2020-VOL. 68, NO. S3 JAGS
50. Mondadori CR, de Quervain DJ, Buchmann A, et al. Better memory and
neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex.
2007;17:1934-1947.
51. Yuan L, Liu J, Dong L, et al. Effects of APOE rs429358, rs7412 and
GSTM1/GSTT1 polymorphism on plasma and erythrocyte antioxidant param-
eters and cognition in old Chinese adults. Nutrients. 2015;7:8261-8273.
52. Shahar S, Lee LK, Rajab N, et al. Association between vitamin A, vitamin E
and apolipoprotein E status with mild cognitive impairment among elderly
people in low-cost residential areas. Nutr Neurosci. 2013;16:6-12.
53. Ridge PG, Hoyt KB, Boehme K, et al. Assessment of the genetic variance of
late-onset Alzheimer’s disease. Neurobiol Aging. 2016;41:200-e213.
54. Pillon B, Deweer B, Agid Y, Dubois B. Explicit memory in Alzheimer’s,
Huntington’s, and Parkinson’s diseases. Arch Neurol. 1993;50:374-379.
55. Aronow WS. Hypertension and cognitive impairment. Ann Transl Med.
2017;5:259.
56. Walker KA, Power MC, Gottesman RF. Defining the relationship between
hypertension, cognitive decline, and dementia: a review. Curr Hypertens Rep.
2017;19:24.
57. Rantalainen V, Lahti J, Henriksson M, et al. APOE and aging-related cognitive
change in a longitudinal cohort of men. Neurobiol Aging. 2016;44:151-158.
58. Ma C, Zhang Y, Li X, et al. Is there a significant interaction effect between
apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment
and gray matter volume? Eur J Neurol. 2016;23:1415-1425.
59. Limon-Sztencel A, Lipska-Ziętkiewicz BS, Chmara M, et al. The algorithm
for Alzheimer risk assessment based on APOE promoter polymorphisms.
Alzheimers Res Ther. 2016;8:19.
60. Choi KY, Lee JJ, Gunasekaran TI, et al. APOE promoter polymorphism-
219T/G is an effect modifier of the influence of APOE ε4 on Alzheimer’s dis-
ease risk in a multiracial sample. J Clin Med. 2019;8:749-763.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the
online version of this article.
Supplementary Figure S1: Q-Q plots for the association
between cognitive measures and 56 known AD risk SNPs in
LASI-DAD.
Supplementary Figure S2: Scatterplots of estimated
effect sizes for cognitive measures in LASI-DAD and
Alzheimer’s disease (AD) from published GWAS.
Supplementary Figure S3: Histograms of the genetic
risk scores (GRSs) in LASI-DAD.
Supplementary Table S1: Alzheimer’s Disease Risk
SNPs from Three Large, Replicated GWASs
Supplementary Table S2: Summary of Known
Alzheimer’s Disease Risk SNPs in LASI-DAD
Supplementary Table S3: Comparison of Observed
Risk Allele Frequency in LASI-DAD Versus Reported Risk
Allele Frequency from Published Alzheimer’s Disease
GWASs
Supplementary Table S4: SNP Associations with Total
Learning Score and Delayed Recall Score
Supplementary Table S5: Correlations Between Effect
Sizes from LASI-DAD and Alzheimer’s Disease GWASs
Supplementary Table S6: SNP-by-Age Interactions on
Total Learning Score and Delayed Recall Score
Supplementary Table S7: Associations Between SNPs
in the APOE Gene/Promoter Region and Total Learning or
Delayed Recall Score
Supplementary Table S8: Interactions Between SNPs
and APOE e2/e4 on Total Learning Score or Delayed
Recall Score
JAGS AUGUST 2020-VOL. 68, NO. S3 ALZHEIMER’S SNPs AND MEMORY IN SOUTH ASIANS S53
